Ninlaro Ixazomib 4 mg

Ninlaro is a prescription cancer drug, used to treat multiple myeloma (bone marrow cancer). To buy Ninlaro or to know its price contact 3S Corporation.

Manufacturer : Takeda Pharmaceuticals U.S.A., Inc.

Strengths available : 4 mg

Form :Capsules

Dosage : The recommended starting dose of Ninlaro is 4 mg administered orally once a week on Days 1, 8, and 15 of a 28-day treatment cycle.

Storage :Do not store above 30°C

Is the medicine US FDA  approved :Yes

Date of Approval :November 20, 2015

Common side effects are Abdominal or stomach pain, black, tarry stools, bloating or swelling of the face, arms, hands, lower legs, or feet, chills, cough, dark urine, diarrhea, dizziness, fever, headache, itching or rash, light-colored stools, loss of appetite, lower back or side pain, nausea, numbness, tingling, or pain in the hands or feet, painful or difficult urination, pale skin, rapid weight gain, rash with flat lesions or small raised lesions on the skin, redness or discoloration of the skin, sore , throat, tingling of the hands or feet, ulcers, sores, or white spots in the mouth, unpleasant breath odor, unusual bleeding or bruising, unusual tiredness or weakness, unusual weight gain or loss, vomiting of blood, yellow eyes or skin.

Contains 3 packs of 1 hard capsules